FindTrial
Sign In

Study on the diagnostic and therapeutic significance of cancer stem cells formation from abnormal tissue stem cells

Study on the diagnostic and therapeutic significance of cancer stem cells formation from abnormal tissue stem cells

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100047924
Enrollment
Unknown
Registered
2021-06-27
Start date
2021-07-01
Completion date
Unknown
Last updated
2022-03-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

glioma

Interventions

case series:none

Sponsors

the First Affiliated Hospital of Army Medical University of PLA
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Glioma cases with surgical resection or puncture; 2. Positive staining of PDGFRA and P53; 3. The patient did not receive radiotherapy or chemotherapy before surgery.

Exclusion criteria

Exclusion criteria: 1. Patients with undetermined tumor grade and unclear diagnosis. 2. Patients with infectious diseases. 3. Patients for which the investigator considers other reasons unsuitable.

Design outcomes

Primary

MeasureTime frame
Anthrax toxin receptor 2;Phosphorylated histone H3;Catenin;Leukocyte differentiation antigen 163;Pleiotropin;SRY box transcription factor 2;Protein tyrosine phosphatase receptor type Z1;Proliferation-associated nuclear antigen Ki67;Platelet-derived growth factor receptor-alpha;Platelet-derived growth factor receptor-beta;Insulin-like growth factor class I receptor;Tyrosine kinase receptor 3;Transforming growth factor beta 2 receptor;Voltage-dependent anion channel 2;—

Countries

America

Contacts

Public ContactBian Xiuwu

The First Affiliated Hospital of the Army Military Medical University of PLA

bianxiuwu@263.net+86 13708373857

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026